Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
171,433,757
-
Share change
-
+5,990,145
-
Total reported value
-
$1,493,108,220
-
Put/Call ratio
-
8.1%
-
Price per share
-
$8.71
-
Number of holders
-
267
-
Value change
-
+$22,502,819
-
Number of buys
-
133
-
Number of sells
-
125
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q1 2024
As of 31 Mar 2024,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
171,433,757 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Sarissa Capital Management LP, STATE STREET CORP, Pacer Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, LSV ASSET MANAGEMENT, ARMISTICE CAPITAL, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and BRAIDWELL LP.
This page lists
258
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.